Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$451M |
| 2 |
STJ
St Jude Medical
STJ
|
+$351M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$290M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
+$282M |
| 5 |
Technology Select Sector SPDR Fund
XLK
|
+$223M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$567M |
| 2 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$411M |
| 3 |
ARG
AIRGAS INC
ARG
|
+$314M |
| 4 |
US Bancorp
USB
|
+$181M |
| 5 |
iShares Biotechnology ETF
IBB
|
+$157M |
Sector Composition
| 1 | Financials | 7.7% |
| 2 | Energy | 6.41% |
| 3 | Technology | 6.36% |
| 4 | Healthcare | 5.52% |
| 5 | Consumer Discretionary | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGPT
2226
DELISTED
VanEck Egypt Index ETF
EGPT
| $447K | ﹤0.01% |
12,639
-10,055
| -44% | -$356K |
|
2227
Frontline
FRO
$5.31B
| $446K | ﹤0.01% |
56,671
-60,967
| -52% | -$480K |
|
2228
Mercury Systems
MRCY
$4.63B
| $446K | ﹤0.01% |
17,989
-21,382
| -54% | -$530K |
|
2229
Sonic Automotive
SAH
$2.73B
| $446K | ﹤0.01% |
26,060
-8,316
| -24% | -$142K |
|
2230
SFL Corp
SFL
$1.07B
| $446K | ﹤0.01% |
30,235
-48,492
| -62% | -$715K |
|
|
NYRT
2231
DELISTED
New York REIT, Inc.
NYRT
| $446K | ﹤0.01% |
4,822
-11,781
| -71% | -$1.09M |
|
|
AMSGP
2232
DELISTED
Amsurg Corp. 5.25% Mandatory Convertible Pft Stk Ser A-1
AMSGP
| $446K | ﹤0.01% |
3,089
-29,684
| -91% | -$4.29M |
|
2233
Bloomin' Brands
BLMN
$579M
| $445K | ﹤0.01% |
24,933
-80,684
| -76% | -$1.44M |
|
|
CHMI
2234
Cherry Hill Mortgage Investment Corp
CHMI
$94.1M
| $445K | ﹤0.01% |
28,559
-86,172
| -75% | -$1.34M |
|
|
SCTY
2235
DELISTED
SolarCity Corporation
SCTY
| $445K | ﹤0.01% |
18,570
-12,953
| -41% | -$310K |
|
2236
Anika Therapeutics
ANIK
$129M
| $444K | ﹤0.01% |
8,273
-2,464
| -23% | -$132K |
|
2237
Mine Safety
MSA
$6.68B
| $444K | ﹤0.01% |
8,457
-12,366
| -59% | -$649K |
|
2238
NETSCOUT
NTCT
$1.87B
| $444K | ﹤0.01% |
19,943
-64,710
| -76% | -$1.44M |
|
2239
Tenaris
TS
$18.3B
| $444K | ﹤0.01% |
15,373
-71,453
| -82% | -$2.06M |
|
2240
Fortune Brands Innovations
FBIN
$6.83B
| $443K | ﹤0.01% |
8,960
+1,460
| +19% | +$72.2K |
|
|
DHY
2241
Credit Suisse High Yield Credit Fund
DHY
$219M
| $441K | ﹤0.01% |
182,917
-1,000
| -0.5% | -$2.41K |
|
2242
Standard Motor Products
SMP
$891M
| $441K | ﹤0.01% |
11,087
-25,419
| -70% | -$1.01M |
|
|
CRAY
2243
DELISTED
Cray, Inc.
CRAY
| $441K | ﹤0.01% |
14,734
-19,043
| -56% | -$570K |
|
2244
City Holding Co
CHCO
$1.84B
| $440K | ﹤0.01% |
9,671
-5,322
| -35% | -$242K |
|
2245
iShares 1-3 Year International Treasury Bond ETF
IGOV
$1.12B
| $440K | ﹤0.01% |
8,830
+7,706
| +686% | +$384K |
|
|
DCM
2246
DELISTED
NTT DOCOMO, Inc.
DCM
| $440K | ﹤0.01% |
16,307
+330
| +2% | +$8.9K |
|
|
CFNL
2247
DELISTED
Cardinal Financial Corp
CFNL
| $440K | ﹤0.01% |
20,053
-17,875
| -47% | -$392K |
|
|
VWR
2248
DELISTED
VWR Corporation
VWR
| $439K | ﹤0.01% |
15,166
+13,637
| +892% | +$395K |
|
2249
Quanta Services
PWR
$58.2B
| $438K | ﹤0.01% |
19,000
-17,367
| -48% | -$400K |
|
2250
Ultragenyx Pharmaceutical
RARE
$2.81B
| $437K | ﹤0.01% |
8,935
-27,950
| -76% | -$1.37M |
|